Skip to Content

Loperamide / simethicone Pregnancy and Breastfeeding Warnings

Loperamide / simethicone is also known as: Imodium Multi-Symptom Relief

Loperamide / simethicone Pregnancy Warnings

Loperamide has been assigned to pregnancy category C by the FDA. Animal studies failed to reveal evidence of teratogenicity or fetal harm. There are no controlled data in human pregnancy.

Simethicone has not been formally assigned to a pregnancy category by the FDA. Loperamide-simethicone should only be given during pregnancy if the potential benefits outweigh the risks.

See references

Loperamide / simethicone Breastfeeding Warnings

Loperamide is excreted into human milk in small amounts. The effects in the nursing infant are unknown. According to the manufacturer, administration of loperamide during lactation is not recommended.

There are no data on the excretion of simethicone into human milk.

See references

References for pregnancy information

  1. "Product Information. Mylicon (simethicone)." Johnson and Johnson Medical Inc, Arlington, TX.
  2. "Product Information. Imodium Advanced (loperamide-simethicone)." Johnson and Johnson/Merck Consumer, Fort Washington, PA.
  3. "Product Information. Imodium (loperamide)." Janssen Pharmaceutica, Titusville, NJ.

References for breastfeeding information

  1. "Product Information. Imodium (loperamide)." Janssen Pharmaceutica, Titusville, NJ.
  2. "Product Information. Mylicon (simethicone)." Johnson and Johnson Medical Inc, Arlington, TX.
  3. "Product Information. Imodium Advanced (loperamide-simethicone)." Johnson and Johnson/Merck Consumer, Fort Washington, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide